share_log

海辰药业(300584.SZ):富马酸丙酚替诺福韦片获得药品注册批件

Nanjing Hicin Pharmaceutical (300584.SZ): Propofol substitute nucleoside antiviral tablets obtained drug registration approval.

Gelonghui Finance ·  Jun 12 04:33

On June 12th, Gelunhui reported that Nanjing Hicin Pharmaceutical (300584.SZ) has recently received a Drug Registration Certificate approved and issued by the National Medical Products Administration, and the drug name is Propofol fumarate Entecavir Tablets. The main component of Propofol fumarate Entecavir Tablets is Propofol fumarate Entecavir (TAF), which is a prodrug of Tenofovir Disoproxil Fumarate (TDF), a potent antiviral drug. TAF has higher stability in plasma, can be more effectively transmitted to liver cells, and achieves similar antiviral effects at much lower doses than TDF, significantly reducing the risk of side effects and having better skeletal and renal safety.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment